Recherche
-
Time to define common European criteria for therapeutic added value
(Thérapie, 2021-04-24)Article de revue -
A UPLC-MS/MS Method for Plasma Biological Monitoring of Nirmatrelvir and Ritonavir in the Context of SARS-CoV-2 Infection and Application to a Case
(Journal of The American Society for Mass Spectrometry. vol. 33, n° 10, pp. 1975-1981, 2022-10-05)Article de revue -
2PRESCRIBE AS INTERNATIONAL AND DIGITAL CASE-BASED PHARMACOTHERAPY EDUCATION AND RESEARCH PLATFORM
(European Journal of Clinical Pharmacology. vol. 78, n° SUPPL 1, pp. S50-S50, 2022-06)Article de revue -
De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring
(Blood. vol. 139, n° 16, pp. 2561-2565, 2022-04-21)Article de revue -
Cardiovascular Adverse Events With Intravitreal Anti-Vascular Endothelial Growth Factor Drugs: A Systematic Review and Meta-analysis of Randomized Clinical Trials
(JAMA Ophthalmology, 2021-04-15)Article de revue -
Features of inflammatory heart reactions following mRNA COVID-19 vaccination at a global level
(Clinical Pharmacology and Therapeutics, 2021-12-03)Article de revueLibre accès -
Myocardial infarction associated with erenumab: a case report.
(PHARMACOTHERAPY, 2022-05-27)Article de revueLibre accès -
High-Dimensional Propensity Score-Adjusted Case-Crossover for Discovering Adverse Drug Reactions from Computerized Administrative Healthcare Databases
(Drug Safety, 2022-02-18)Article de revue -
A meta-epidemiological study found lack of transparency and poor reporting of disproportionality analyses for signal detection in pharmacovigilance databases
(Journal of Clinical Epidemiology, 2021-07-27)Article de revue -
General practitioners' compliance with benzodiazepine discontinuation guidelines in patients treated with long-term lorazepam: A case-vignette cross-sectional survey
(Thérapie, 2021-09-16)Article de revue